Meredith Manning, Chief Commercial Officer at SOLENO THERAPEUTICS INC (SLNO), sold 52,416 shares at $69.84 ($3.5M) on 2025-03-27, disclosed to the SEC on 2025-03-31.
Open-market sale of $3.5M SLNO by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.97 | 668 | $44K | 1.2% |
| 2 | $66.79 | 1,087 | $73K | 2.1% |
| 3 | $66.79 | 1,087 | $73K | 2.1% |
| 4 | $67.04 | 37,000 | $2.5M | 70.2% |
| 5 | $67.70 | 1,976 | $134K | 3.8% |
| 6 | $67.70 | 1,976 |
| $134K |
| 3.8% |
| 7 | $68.79 | 2,599 | $179K | 5.1% |
| 8 | $68.79 | 2,599 | $179K | 5.1% |
| 9 | $69.84 | 1,505 | $105K | 3.0% |
| 10 | $69.84 | 1,505 | $105K | 3.0% |
| 11 | $70.73 | 155 | $11K | 0.3% |
| 12 | $71.74 | 225 | $16K | 0.5% |
| 13 | $72.64 | 34 | $2K | 0.1% |
| Total | $67.43 avg | 52,416 | $3.5M | 100% |